References
- Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. https://doi.org/10.1161/01.CIR.0000145143.19711.78
- Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 2003;24:122-6. https://doi.org/10.1007/s00246-002-0063-1
- Manlhiot C, Yeung RS, Clarizia NA, Chahal N, McCrindle BW. Kawasaki disease at the extremes of the age spectrum. Pediatrics 2009;124:e410-5. https://doi.org/10.1542/peds.2009-0099
- Council on Cardiovascular Disease in the Young, Committee on Rheumatic Fever Endocarditis, and Kawasaki Disease, American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation 2001;103:335-6. https://doi.org/10.1161/01.CIR.103.2.335
- Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232-4. https://doi.org/10.1111/j.1442-200x.2005.02033.x
- Seo JH, Yu JJ, Ko HK, Choi HS, Kim YH, Ko JK. Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guerin inoculation site. Korean Circ J 2012;42:823-9. https://doi.org/10.4070/kcj.2012.42.12.823
- Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease. J Pediatr 2013;162:1205-9. https://doi.org/10.1016/j.jpeds.2012.11.026
- Olivieri L, Arling B, Friberg M, Sable C. Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography. J Am Soc Echocardiogr 2009;22:159-64. https://doi.org/10.1016/j.echo.2008.11.003
- Japan Kawasaki Disease Research Committee. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health and Welfare; 1984.
- Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
- Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85. https://doi.org/10.1161/01.CIR.94.6.1379
- Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 2006;25:241-4. https://doi.org/10.1097/01.inf.0000202067.50975.90
- Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY. Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 2006;39:387-91.
- Hsieh YC, Wu MH, Wang JK, Lee PI, Lee CY, Huang LM. Clinical features of atypical Kawasaki disease. J Microbiol Immunol Infect 2002;35:57-60.
- Perrin L, Letierce A, Guitton C, Tran TA, Lambert V, Kone-Paut I. Comparative study of complete versus incomplete Kawasaki disease in 59 pediatric patients. Joint Bone Spine 2009;76:481-5. https://doi.org/10.1016/j.jbspin.2008.11.015
- Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80. https://doi.org/10.1161/01.CIR.87.5.1776
- Sinha R, Balakumar T. BCG reactivation: a useful diagnostic tool even for incomplete Kawasaki disease. Arch Dis Child 2005;90:891. https://doi.org/10.1136/adc.2004.071332
- Chalmers D, Corban JG, Moore PP. BCG site inflammation: a useful diagnostic sign in incomplete Kawasaki disease. J Paediatr Child Health 2008;44:525-6. https://doi.org/10.1111/j.1440-1754.2008.01364.x
- Uehara R, Igarashi H, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site. Pediatr Infect Dis J 2010;29:430-3. https://doi.org/10.1097/INF.0b013e3181cacede
- Lai CC, Lee PC, Wang CC, Hwang BT, Meng CC, Tsai MC. Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease. Pediatr Neonatol 2013;54:43-8. https://doi.org/10.1016/j.pedneo.2012.10.003
- Plantin P, Blayo M, Dupré D, Schoenlaub P. BCG reactivation: a rare but specific sign of Kawasaki disease. Presse Med 1998;27:716.
- Mukoyama M, Nakao K, Saito Y, et al. Human brain natriuretic peptide, a novel cardiac hormone. Lancet 1990;335:801-2. https://doi.org/10.1016/0140-6736(90)90925-U
- Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995;214:1175-83. https://doi.org/10.1006/bbrc.1995.2410
Cited by
- A 3-month-old infant with atypical Kawasaki disease vol.2018, pp.may_129, 2015, https://doi.org/10.1136/bcr-2017-221456
- Recent advances in the diagnosis of Kawasaki disease vol.5, pp.1, 2015, https://doi.org/10.22470/pemj.2018.00220
- N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease vol.13, pp.4, 2015, https://doi.org/10.2217/bmm-2018-0324
- N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease vol.13, pp.4, 2015, https://doi.org/10.2217/bmm-2018-0324
- Kawasaki Disease in Infants in the First 3 Months of Age in a Mexican Population: A Cautionary Tale vol.8, pp.None, 2020, https://doi.org/10.3389/fped.2020.00397
- Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease vol.106, pp.7, 2015, https://doi.org/10.1136/archdischild-2020-319543
- Diagnostic accuracy of N‐terminal pro‐brain natriuretic peptide for Kawasaki disease: An updated systematic review and meta‐analysis vol.75, pp.11, 2015, https://doi.org/10.1111/ijcp.14538